 |
인쇄하기
취소
|
CrystalGenomics joins hands with AstraZeneca
CrystalGenomics Inc., a local biopharmaceutical company, services, said on January 12 that it has signed a contract with AstraZeneca Plc to jointly develop a new antibiotic to treat superbacteria.
Financial terms of the contract were not disclosed. Under the contract, London-based AstraZeneca will provide funds for CrystalGenomics to develop the antibiotic over the next two years, the Korean...
Financial terms of the contract were not disclosed. Under the contract, London-based AstraZeneca will provide funds for CrystalGenomics to develop the antibiotic over the next two years, the Korean...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.